0000932471-25-000733.txt : 20250729
0000932471-25-000733.hdr.sgml : 20250729
20250729110552
ACCESSION NUMBER: 0000932471-25-000733
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250729
DATE AS OF CHANGE: 20250729
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc.
CENTRAL INDEX KEY: 0001390478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-84090
FILM NUMBER: 251158897
BUSINESS ADDRESS:
STREET 1: 7 TIMES SQUARE
STREET 2: SUITE 2503
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 6462005278
MAIL ADDRESS:
STREET 1: 7 TIMES SQUARE
STREET 2: SUITE 2503
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Galena Biopharma, Inc.
DATE OF NAME CHANGE: 20110926
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20110926
FORMER COMPANY:
FORMER CONFORMED NAME: GALENA BIOPHARMA, INC.
DATE OF NAME CHANGE: 20110922
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: VANGUARD GROUP INC
CENTRAL INDEX KEY: 0000102909
ORGANIZATION NAME:
EIN: 231945930
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 100 VANGUARD BLVD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 6106691000
MAIL ADDRESS:
STREET 1: PO BOX 2600
STREET 2: V26
CITY: VALLEY FORGE
STATE: PA
ZIP: 19482-2600
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0000102909
XXXXXXXX
LIVE
Common Stock
06/30/2025
0001390478
SELLAS Life Sciences Group Inc
81642T209
7 TIMES SQUARE
SUITE 2503
NEW YORK
NY
10036
Rule 13d-1(b)
The Vanguard Group
PA
0
92960
6568778
126021
6694799
6.70
IA
The holdings reported herein are in the form of warrants.The CUSIP Number listed throughout this filing is the CUSIP assigned to the Ordinary Shares of the Issuer.
SELLAS Life Sciences Group Inc
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
The Vanguard Group
100 Vanguard Blvd., Malvern, PA 19355
PA
N
IA
6694799
6.7
0
92960
6568778
126021
Y
N
The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
No one other person's interest in the securities reported herein is more than 5%.
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
The Vanguard Group
Ashley Grim
Head of Global Fund Administration
07/29/2025